Expansion plans are based on requests for product access received from surgeons and hospitals in Israel - - Expansion of Symvess into other territories, including those in Europe and the Middle East, ...
Aktis Oncology is seeking a valuation of as much as $840 million in its U.S. initial public offering, the biotechnology company backed by major sector investor MPM BioImpact revealed in a filing on ...
Tango Therapeutics, Inc. (NASDAQ: TNGX), a clinical-stage biotechnology company committed to discovering and delivering the next generation of precision cancer medicines, today announced the ...
Here is STAT’s biotech scorecard, our regular ledger of stock-moving biotech events, for the first quarter: Alumis: Top-line ...
At Permea, we focus on what truly matters in skincare - ABSORPTION. Today, most skincare brands compete on ingredients, ...
Can gene editing truly support smallholder farmers and help Indonesia achieve food sovereignty, or will it simply revive the old controversies surrounding GMO crops?
These include jobs in high paying growth industries such as finance, biotechnology, and information technology. California is ...
A 2022 review in the Journal of Food Quality and Health noted that while no health hazards from GMOs have been proven in ...
Climate-resilient agriculture uses biotechnology, biofertilizers, biopesticides, genome-edited crops, and AI-driven tools to ...
Our goal with CosmeticAI™ was to make cosmetic ingredient development predictable rather than exploratory” — Dr. Lurong Pan, CEO of Ainnocence SAN FRANSICO, CA, UNITED STATES, January 1, 2026 ...
Most biotech firms will be forced to reevaluate foreign relationships and re-route supply chains, or hope for a federal ...
The performance metrics speak volumes. The iShares Biotechnology ETF (NASDAQ: IBB) has climbed 29.51% year to date through December 29, while the State Street SPDR S&P Biotech ETF (NASDAQ: XBI) has ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results